What are the differences in pathophysiology, laboratory findings, and management between metabolic alkalosis and contraction alkalosis?

Metabolic Alkalosis vs Contraction Alkalosis: Key Differences and Clinical Approach

Core Distinction

"Contraction alkalosis" is a misnomer—the correct term is chloride-depletion alkalosis, because chloride deficiency, not volume contraction per se, is the primary driver of persistent metabolic alkalosis. 1 While volume contraction often accompanies chloride loss, studies demonstrate that chloride repletion alone corrects the alkalosis even when volume contraction, sodium depletion, and potassium depletion persist. 1

---

Pathophysiology: Generation vs Maintenance

Generation Phase

Metabolic alkalosis is generated by either net bicarbonate gain or net acid loss from the extracellular fluid. 2, 3

• Acid loss via gastrointestinal tract: Vomiting or nasogastric suction removes hydrochloric acid, leading to bicarbonate accumulation. 2, 3
• Acid loss via kidney: Loop or thiazide diuretics increase distal sodium delivery and aldosterone activity, promoting hydrogen ion secretion and bicarbonate reabsorption. 4, 2
• Alkali gain: Excessive oral or parenteral bicarbonate, lactate (from Lactated Ringer's), acetate, or citrate (during CRRT) can introduce excess alkali. 4, 3

Maintenance Phase: Why the Kidney Fails to Correct

Normally, the kidney eliminates excess bicarbonate by increasing filtration and decreasing proximal tubular reabsorption. 2, 3 However, several factors impair this corrective mechanism and maintain the alkalosis:

• Chloride depletion (hypochloremia): The most critical factor—chloride deficiency directly impairs bicarbonate excretion, primarily by affecting pendrin (a Cl⁻/HCO₃⁻ exchanger in the collecting duct). 1, 4
• Volume contraction: Reduces glomerular filtration rate and enhances proximal bicarbonate reabsorption via increased sodium-hydrogen exchange. 2, 3, 5
• Hypokalemia: Potassium deficiency promotes intracellular hydrogen ion shift and increases renal bicarbonate reabsorption. 2, 3
• Aldosterone excess: Increases distal hydrogen ion secretion and bicarbonate generation. 2, 3
• Reduced GFR: Decreases filtered bicarbonate load, limiting renal excretion capacity. 2, 3

---

Laboratory Findings

Serum Chemistry

• Elevated serum bicarbonate (>26 mmol/L) and arterial pH >7.45 define metabolic alkalosis. 4, 2
• Hypochloremia (serum Cl⁻ <99 mmol/L, often 85–95 mmol/L) is characteristic of chloride-depletion alkalosis. 4
• Hypokalemia (K⁺ <3.5 mmol/L) is common but may be normal initially. 4
• Compensatory respiratory acidosis: PaCO₂ rises by approximately 0.7 mmHg for every 1 mEq/L increase in bicarbonate. 2

Urinary Chloride: The Critical Diagnostic Test

Urinary chloride concentration distinguishes chloride-responsive from chloride-resistant alkalosis and guides treatment. 4, 2

• Urinary Cl⁻ <20 mEq/L (chloride-responsive): Indicates volume depletion and chloride deficiency—seen with vomiting, nasogastric suction, remote diuretic use, or post-hypercapnic alkalosis. 4, 2
• Urinary Cl⁻ >20 mEq/L (chloride-resistant): Suggests ongoing renal losses (current diuretic use), mineralocorticoid excess, Bartter/Gitelman syndrome, or severe hypokalemia. 4, 2

Additional Markers

• Fractional excretion of chloride >0.5% indicates renal salt-wasting (Bartter/Gitelman syndrome or diuretic abuse). 4
• Elevated plasma renin and aldosterone suggest secondary hyperaldosteronism from volume depletion or primary mineralocorticoid excess. 4

---

Clinical Presentations

Chloride-Depletion (Contraction) Alkalosis

This is the most common form of metabolic alkalosis in hospitalized patients, typically caused by gastrointestinal losses or diuretic therapy. 2, 6

• Vomiting or nasogastric suction: Direct loss of HCl with secondary volume contraction and chloride depletion. 2, 3
• Loop or thiazide diuretics: Cause urinary chloride, sodium, and water losses, leading to volume contraction and compensatory bicarbonate retention. 4, 2
• Post-hypercapnic alkalosis: Chronic respiratory acidosis with compensatory bicarbonate retention; rapid correction of hypercapnia leaves excess bicarbonate. 7

Clinical signs: Orthostatic hypotension, decreased skin turgor, elevated BUN/creatinine ratio, and urinary chloride <20 mEq/L (once diuretics are stopped). 4

Chloride-Resistant Alkalosis

• Mineralocorticoid excess: Primary hyperaldosteronism, Cushing syndrome, or exogenous corticosteroids cause hypertension, hypokalemia, and urinary chloride >20 mEq/L. 2, 3
• Bartter/Gitelman syndrome: Genetic salt-losing tubulopathies presenting with hypokalemic metabolic alkalosis, hypochloremia, elevated urinary chloride (>20 mEq/L), normal-to-low blood pressure, and secondary hyperaldosteronism. 4, 2
• Severe hypokalemia (K⁺ <2.0 mEq/L): Can maintain alkalosis even with adequate chloride. 2

---

Management Algorithm

Step 1: Assess Severity and Hemodynamics

• Severe alkalosis (pH >7.55) is associated with significantly increased mortality in critically ill patients and requires aggressive intervention. 2
• Evaluate volume status: Check for orthostatic hypotension, jugular venous pressure, edema, and BUN/creatinine ratio. 4

Step 2: Measure Urinary Chloride

This single test determines the treatment pathway. 4, 2

Step 3: Chloride-Responsive Alkalosis (Urinary Cl⁻ <20 mEq/L)

The cornerstone of treatment is volume repletion with isotonic saline (0.9% NaCl) to restore extracellular volume and provide chloride. 4, 2

• Isotonic saline (0.9% NaCl): Administer at rates sufficient to correct volume deficit—typically 15–20 mL/kg over the first hour in severe depletion, then 4–14 mL/kg/h. 4
• Potassium chloride supplementation: Essential when hypokalemia is present—doses of 20–60 mEq/day are often required to maintain serum K⁺ at 4.5–5.0 mEq/L. 4 Use only potassium chloride, never potassium citrate or bicarbonate, as these worsen alkalosis. 4
• Discontinue or reduce diuretics if clinically feasible. 4

Common pitfall: Administering potassium without adequate chloride (e.g., using potassium citrate) will fail to correct the alkalosis because chloride deficiency is the primary driver. 4, 1

Step 4: Chloride-Resistant Alkalosis (Urinary Cl⁻ >20 mEq/L)

First-line therapy is potassium-sparing diuretics, particularly amiloride or spironolactone. 4

• Amiloride: Start 2.5 mg daily, titrate to 5 mg daily—most effective for countering diuretic-induced alkalosis. 4
• Spironolactone: Start 25 mg daily, titrate to 50–100 mg daily—particularly useful in heart failure or primary hyperaldosteronism. 4
• Avoid combining with ACE inhibitors or ARBs without close monitoring due to hyperkalemia risk. 4
• Potassium chloride supplementation: 20–60 mEq/day to maintain K⁺ 4.5–5.0 mEq/L. 4

Step 5: Severe or Refractory Alkalosis

Acetazolamide (500 mg IV single dose) rapidly lowers serum bicarbonate by inhibiting proximal tubular bicarbonate reabsorption—use only if kidney function is adequate (eGFR >30 mL/min). 4, 2

• Indications: Heart failure with diuretic-induced alkalosis, adequate renal function, and pH >7.55. 4
• Contraindications: Significant renal impairment, hyperkalemia, or metabolic acidosis. 4
• Monitor closely for hypokalemia, as acetazolamide increases urinary potassium losses. 4

In refractory cases with concurrent renal failure, hemodialysis with low-bicarbonate/high-chloride dialysate is the treatment of choice. 4

Step 6: Special Populations

Bartter/Gitelman Syndrome

These genetic tubulopathies require lifelong management with sodium chloride supplementation (5–10 mmol/kg/day), potassium chloride, and NSAIDs (indomethacin or ibuprofen) to reduce prostaglandin-mediated salt wasting. 4

• Always co-prescribe gastric acid inhibitors (PPIs) with NSAIDs to prevent gastrointestinal complications. 4
• Genetic testing (SLC12A1, KCNJ1 for Bartter; SLC12A3 for Gitelman) confirms diagnosis. 4
• Urinary calcium differentiates: High in Bartter, low in Gitelman. 4

Heart Failure with Diuretic-Induced Alkalosis

• Add aldosterone antagonist (spironolactone 25–50 mg daily) to the diuretic regimen. 4
• Consider acetazolamide if bicarbonate >35 mmol/L and eGFR >30 mL/min. 4
• Optimize heart failure management to reduce diuretic requirements. 4

---

Key Clinical Pitfalls

• Mistaking volume contraction as the sole cause: Chloride deficiency is the primary driver—volume repletion without chloride (e.g., using 5% dextrose) will not correct the alkalosis. 1
• Using non-chloride potassium salts: Potassium citrate or bicarbonate worsens alkalosis; always use potassium chloride. 4
• Overlooking Bartter/Gitelman syndrome: Consider in euvolemic patients with unexplained hypokalemic metabolic alkalosis, normal blood pressure, and elevated urinary chloride. 4
• Aggressive bicarbonate correction in compensated respiratory acidosis: Elevated bicarbonate may represent appropriate compensation for chronic hypercapnia—focus on managing the underlying respiratory disorder, not the bicarbonate. 7
• Combining potassium-sparing diuretics with ACE inhibitors without monitoring: High risk of life-threatening hyperkalemia. 4

---

Monitoring Parameters

• Serum electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻): Every 2–4 hours during acute treatment, then daily until stable. 4, 2
• Arterial or venous blood gas: Initially to confirm diagnosis and assess severity; venous pH is acceptable for ongoing monitoring (typically 0.03 units lower than arterial). 4
• Urinary chloride: Repeat if clinical response is inadequate to reassess etiology. 4
• Volume status: Blood pressure, orthostatic vitals, urine output, and BUN/creatinine ratio. 4